Showing results (571-580 of 608) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 9, 2024
Clinical outcomes after use of checkpoint inhibitor immunotherapies in people with multiple sclerosisAlyssa N Nylander, William Rowles, Shane Poole, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 24, 2024
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational ProgramMarco Salvetti, Sibyl Wray, Gereon Nelles, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 27, 2024
Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBaseTim Spelman, Sara Eichau, Raed Alroughani, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 23, 2026
Leptomeningeal enhancement in multiple sclerosis demonstrates posterior predilection and T1 alterations in the adjacent cortexAshley A Thommana, Erin S Beck, Matthew A Greenwald, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 30, 2026
Apolipoprotein E4 and its later-life health effects on the multiple sclerosis populationDean Zeldich, Chia Hsin Cheng, Yi Guan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 16, 2026
Association of treatment decision with personality, coping strategies and impulsivity in patients with multiple sclerosisJan Philipp Nolte, Fabian Föttinger, Nik Krajnc, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 12, 2025
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practiceHesham Abboud, Brian Steingo, Diana Vargas, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 28, 2025
Retinal ganglion cell loss is associated with multimodal visual dysfunction following demyelinating optic neuritisMustafa Subhi, Sargis Manukyan, Gabriela Zabala, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 9, 2025
Barriers to care for people with unclear visual loss-Data from a tertiary-level-of-care neuroinflammation centerMurat Delikaya, Charlotte Bereuter, Jan Schroeter, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 13, 2023
Humoral immune response after Ad26.COV2.S vaccination in patients with multiple sclerosis treated with natalizumabMark Gudesblatt, Myassar Zarif, Barbara Bumstead, et al.
Pageof 61